WHO cautious on Covid-19 plasma as US issues emergency authorization
"There are a number of clinical trials going on around the world looking at convalescent plasma compared to the standard of care," Soumya Swaminathan, WHO chief scientist, said
A logo is pictured at the World Health Organization (WHO) building in Geneva, Switzerland, February 2, 2020. Picture taken February 2, 2020. REUTERS/Denis Balibouse
The World Health Organization on Monday was cautious about endorsing the use of recovered Covid-19 patients' plasma to treat people who are ill, saying evidence it works remains "low quality" even as the United States issued emergency authorization for such therapies.
"There are a number of clinical trials going on around the world looking at convalescent plasma compared to the standard of care," Soumya Swaminathan, WHO chief scientist, said.
"Only a few of them have actually reported interim results...and at the moment, it's still very low-quality evidence," she told a news conference.
Keep updated, follow The Business Standard's Google news channel
